Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | -239,679 | 32,657 | 34,347 | 18,375 | 16,604 |
| Operating Income | 239,679 | -32,657 | -34,347 | -18,375 | -16,604 |
| Other Income | 456 | 197 | 141 | 116 | 165 |
| Pre-tax Income | 240,135 | -32,460 | -34,206 | -18,259 | -16,439 |
| Income Tax | 66,070 | -19,568 | N/A | 0 | 0 |
| Net Income Continuous | 174,065 | -12,892 | -34,206 | -18,259 | -16,439 |
| Minority Interests | -833 | -794 | -1,692 | -909 | -803 |
| Net Income | $174,898 | $-12,098 | $-32,514 | $-17,350 | $-15,636 |
| EPS Basic Total Ops | 3.90 | -0.27 | -0.76 | -0.40 | -0.36 |
| EPS Basic Continuous Ops | 3.88 | -0.29 | -0.80 | -0.42 | -0.38 |
| EPS Diluted Total Ops | 3.77 | -0.27 | -0.76 | -0.40 | -0.36 |
| EPS Diluted Continuous Ops | 3.75 | -0.29 | -0.80 | -0.42 | -0.38 |
| EBITDA(a) | $239,691 | $-32,644 | $-34,335 | $-18,362 | $-16,591 |